These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4213267)

  • 21. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
    Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin.
    Bak IJ; Hassler R; Kim JS
    Z Zellforsch Mikrosk Anat; 1969; 101(3):448-62. PubMed ID: 5362847
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
    Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
    Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of (+-)-p-chloroamphetamine on the susceptiblity to seizures and on the monoamine level in brain and heart of mice and rats.
    Pfeifer AK; Galambos E
    J Pharm Pharmacol; 1967 Jun; 19(6):400-2. PubMed ID: 4382372
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of chorionic gonadotrophin on brain amine levels in male rats.
    Montgomery RL; Christian EL
    Pharmacol Biochem Behav; 1973; 1(6):735-7. PubMed ID: 4785811
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine.
    Alpers HS; Himwich HE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):531-8. PubMed ID: 5012780
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Neuroendocrinology; 1977; 23(4):236-47. PubMed ID: 409963
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain.
    Breese GR; Cooper BR; Grant LD; Smith RD
    Neuropharmacology; 1974 Mar; 13(3):177-87. PubMed ID: 4407423
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG; Corrodi H; Masuoka DT
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover.
    Thierry AM; Javoy F; Glowinski J; Kety SS
    J Pharmacol Exp Ther; 1968 Sep; 163(1):163-71. PubMed ID: 5673703
    [No Abstract]   [Full Text] [Related]  

  • 32. The mechanism of tissue norepinephrine depletion by alpha, alpha'-dipyridyl.
    Bapna J; Neff NH; Costa E
    Neuropharmacology; 1970 Jul; 9(4):333-40. PubMed ID: 5456579
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 34. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol].
    Shevchenko TP; Tolpyshev BA; Zban' LN
    Eksp Klin Farmakol; 1993; 56(3):15-7. PubMed ID: 8219980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.
    Bloom FE; Algeri S; Groppetti A; Revuelta A; Costa E
    Science; 1969 Dec; 166(3910):1284-6. PubMed ID: 5350323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of 5-hydroxytryptamine, dopamine and norepinephrine in whole brain of rabbits in chronic manganese toxicity.
    Mustafa SJ; Chandra SV
    J Neurochem; 1971 Jun; 18(6):931-3. PubMed ID: 5567911
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of repeated flurothyl-induced seizures on convulsive thresholds and brain monoamines in rats.
    Adler MW; Sagel S; Kitagawa S; Segawa T; Maynert EW
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):12-21. PubMed ID: 4383498
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent acquisitions on cerebral metabolism of catecholamines].
    Glowinski J
    Actual Pharmacol (Paris); 1967; 20():29-68. PubMed ID: 4894123
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 40. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD; Cattabeni F; Costa E
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.